06:01 PM EDT, 05/28/2024 (MT Newswires) -- Cytek Biosciences ( CTKB ) said Tuesday it received approval from China's National Medical Products Administration for the clinical diagnostic use of its 1-laser and 2-laser 6-color TBNK reagent cocktails in hospitals, laboratories and clinics.

The TBNK reagents help in diagnosing and monitoring various immune-related conditions, including immunodeficiencies, autoimmune diseases, infectious diseases and cancers.